Rockwell Medical Inc
RMTI
Company Profile
Business description
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Contact
30142 S. Wixom Road
WixomMI48393
USAT: +1 248 960-9009
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
237
Stocks News & Analysis
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
What next for Tesla as 2024 deliveries disappoint?
Tesla shares started the year on a sour note. We think they continue to price in ambitious growth going forward.
stocks
Best and worst performing ASX sectors of 2024
Exploring the ASX sectors that moved the market this year.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,542.90 | 26.40 | 0.31% |
| CAC 40 | 7,509.64 | 63.95 | 0.86% |
| DAX 40 | 20,359.92 | 143.73 | 0.71% |
| Dow JONES (US) | 42,706.56 | 25.57 | -0.06% |
| FTSE 100 | 8,226.52 | 23.14 | -0.28% |
| HKSE | 19,447.58 | 240.71 | -1.22% |
| NASDAQ | 19,864.98 | 243.30 | 1.24% |
| Nikkei 225 | 40,083.30 | 776.25 | 1.97% |
| NZX 50 Index | 13,042.06 | 30.87 | -0.24% |
| S&P 500 | 5,975.38 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,285.10 | 27.70 | 0.34% |
| SSE Composite Index | 3,229.64 | 22.72 | 0.71% |